- Report
- April 2024
- 180 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- April 2024
- 185 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- February 2024
- 186 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- February 2024
- 185 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- January 2024
- 190 Pages
Global
From €4444EUR$4,500USD£3,698GBP
- Report
- August 2024
- 150 Pages
Global
From €2593EUR$2,625USD£2,157GBP
€3704EUR$3,750USD£3,082GBP
- Report
- July 2024
- 150 Pages
Global
From €2593EUR$2,625USD£2,157GBP
€3704EUR$3,750USD£3,082GBP
- Report
- August 2024
- 153 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- August 2024
- 138 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- August 2024
- 168 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- July 2024
- 168 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- July 2024
- 166 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- July 2024
- 139 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2024
- 167 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2024
- 164 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- May 2024
- 176 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- February 2024
- 161 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- February 2024
- 154 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- September 2024
- 200 Pages
Global
From €4937EUR$4,999USD£4,108GBP
- Report
- August 2024
- 200 Pages
Global
From €3950EUR$3,999USD£3,286GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more